GSK, Sanofi and CSL Ltd have secured $72 million from the US government to ramp up production of bird flu vaccines, Reuters ...
David Boucher, the director of infectious disease preparedness and response at the Administration for Strategic Preparedness and Response, noted the government recently invested $72 million to boost ...
Test results are pending on a worker who had contact with infected herds, California officials report. Meanwhile, federal scientists are studying H5N1 genes in dairy workers in search of mutations ...
Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the drugmaker to make changes ...
Six health care workers in the US who were in close contact with a patient known to have bird flu developed mild respiratory ...
GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...
The justices will consider the constitutionality of state laws banning gender-affirming care for minors for the first time.
The FDA has cleared GSK's PD-1 inhibitor Jemperli as a treatment for all adult patients with primary advanced or recurrent endometrial cancer, a key part of the company's growth ambitions for the ...